Results 51 to 60 of about 120,253,457 (190)

Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications

open access: yes, 2022
Immunoadsorption is well known to selectively remove immunoglobulins and immune complexes from plasma and is applied in a variety of autoimmune diseases and for desensitization before, or at acute rejection after organ transplantation.
Christian Morath   +21 more
core   +1 more source

Thai Transplant Care Practice Guideline on Immunosuppressive Therapy for Adult Kidney Transplantation

open access: yesNephrology, Volume 31, Issue S2, September 2026.
ABSTRACT The Thai Transplantation Society developed these clinical practice guidelines to establish a comprehensive standard for immunosuppressive therapy in adult kidney transplantation. While rooted in evidence‐based medicine, the objective of this document extends beyond local application, serving as a practical model for low‐to‐middle‐income ...
Suwasin Udomkarnjananun   +12 more
wiley   +1 more source

Staphylococcyl Protein A Immunoadsorption: Its Use, Effect, And Proposed Mechanisms Of Action [PDF]

open access: yes, 1989
Four patients, two with Idiopathic Thrombocytopenic Purpura, one with advanced Astrocytoma, and one with Systemic Lupus Neutropenia, were treated with the Prosorba® Immunoadsorption Column on an out-patient basis.
Stein, Edward
core  

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 8, Page 1697-1701, August 2026.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos   +9 more
wiley   +1 more source

Outcomes in Recurrent Focal Segmental Glomerulosclerosis Post‐Kidney Transplantation Treated With Therapeutic Plasma Exchange: A Retrospective Cohort Study

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 4, August 2026.
ABSTRACT Recurrence of focal segmental glomerulosclerosis (FSGS) following kidney transplantation remains a significant cause of allograft loss. Much remains unknown about the efficacy of apheresis treatments and the factors that determine favorable treatment outcomes.
Chimezie Godswill Okwuonu   +4 more
wiley   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1106-1117, June 2026.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

Costs for immunoadsorption.

open access: yes, 2015
All prices are shown in Euro. Expenses do not include replacement fluids and labor costs.Costs for immunoadsorption.
Stefan Reuter (199795)   +8 more
core   +1 more source

Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis

open access: yesJournal of Neuroinflammation, 2012
Background In multiple sclerosis relapses refractory to intravenous corticosteroid therapy, plasma exchange is recommended. Immunoadsorption (IA) is regarded as an alternative therapy, but its efficacy and putative mechanism of action still needs to be ...
Koziolek Michael J   +8 more
doaj   +1 more source

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

open access: yesFrontiers in Immunology, 2020
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by autoantibodies targeting neuromuscular junction proteins.
Konstantinos Lazaridis   +2 more
doaj   +1 more source

Porcine kidney xenotransplantation: From primate models to clinical reality

open access: yesAnimal Models and Experimental Medicine, Volume 9, Issue 6, Page 1142-1166, June 2026.
In the face of a critical shortage of human donor kidneys for end‐stage renal disease patients, porcine kidney xenotransplantation has emerged as a viable solution. This field has navigated major hurdles, including immune rejection, physiological incompatibilities, potential biomechanical differences and the risk of cross‐species infection. To overcome
Zihang Guo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy